A 2.5-year-old child receiving phenobarbital for a history of seizures
while on continuous cycling peritoneal dialysis (CCPD) had persistent
subtherapeutic serum levels despite progressive dosage increases. Phe
nobarbital concentration was measured in the peritoneal dialysate effl
uent and peritoneal clearance was calculated. Thirty-five percent of t
he total phenobarbital daily dose was being removed through 24-hour CC
PD. Our findings were consistent with previous reports of 40% and 50%
phenobarbital removal during continuous ambulatory peritoneal dialysis
and acute peritoneal dialysis, respectively. In addition, phenobarbit
al clearance was greater during the period when more exchanges were do
ne compared with the period when patient went through one cycle with a
longer dwell time. Based on these preliminary data, it seems that lar
ger dosages of phenobarbital are necessary in patients undergoing cont
inuous peritoneal dialysis, and that the amount removed can differ sig
nificantly depending on the number of cycles.